KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Depreciation and Depletion (2018 - 2025)

Biogen has reported Depreciation and Depletion over the past 8 years, most recently at $68.0 million for Q4 2025.

  • Quarterly results put Depreciation and Depletion at $68.0 million for Q4 2025, down 6.59% from a year ago — trailing twelve months through Dec 2025 was $272.8 million (down 4.85% YoY), and the annual figure for FY2025 was $272.8 million, down 4.85%.
  • Depreciation and Depletion for Q4 2025 was $68.0 million at Biogen, up from $66.5 million in the prior quarter.
  • Over the last five years, Depreciation and Depletion for BIIB hit a ceiling of $76.3 million in Q1 2022 and a floor of $48.8 million in Q1 2021.
  • Median Depreciation and Depletion over the past 5 years was $66.6 million (2021), compared with a mean of $66.1 million.
  • Biggest five-year swings in Depreciation and Depletion: skyrocketed 56.35% in 2022 and later dropped 18.61% in 2023.
  • Biogen's Depreciation and Depletion stood at $66.6 million in 2021, then decreased by 2.85% to $64.7 million in 2022, then decreased by 1.85% to $63.5 million in 2023, then increased by 14.65% to $72.8 million in 2024, then decreased by 6.59% to $68.0 million in 2025.
  • The last three reported values for Depreciation and Depletion were $68.0 million (Q4 2025), $66.5 million (Q3 2025), and $66.9 million (Q2 2025) per Business Quant data.